Prescribing
19 results
Applied filters
Medications for treating CRS and ICANS
2 October 2026Guidance on which medications to use when treating CRS and ICANS.
Diagnosis and management of ICANS
2 October 2026Guidance on the management of immune effector cell-associated neurotoxicity syndrome (ICANS) in adults receiving licensed CAR-T cell products.
Diagnosis and management of cytokine release syndrome (CRS)
2 October 2026Guidance on the management of CRS in adult patients receiving licensed CAR-T cell products.
Understanding acute CAR-T cell therapy toxicities in adults
2 October 2026Guidance on the management of acute side effects in adults receiving licensed CAR-T cell therapy products.
Prescribing with confidence podcast series
22 June 2026Exploring real-world prescribing through expert insights, practical tools, and lived experiences to support prescribers in developing safe, confident practice.
Example medicines to prescribe by brand name
2 April 2026Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
Prescribing by generic or brand name
31 March 2026Prescribing medicines by generic name is generally preferred but there are some clinical circumstances when brand-name prescribing is warranted.
Prescribing controlled drugs for dental teams
16 March 2026This article explains which controlled drugs (CDs) dentists may prescribe, how to prescribe them, and on which forms.
Supportive medicines guidance for adults on CAR-T cell therapy
11 February 2026This document provides expert clinical pharmacy guidance on supportive medicines in order to facilitate the treatment of complex CAR-T Cell Therapy patients.
Medication restrictions for CAR-T cell therapy
11 February 2026CAR-T Therapy requires some medicines to be restricted, this guidance provides details and recommended wash-out periods for restricted medicines.